BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8062272)

  • 1. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
    Strohal R; Paucz L; Pehamberger H; Stingl G
    Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J; Birck A; Straten PT
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
    Ikeda H; Sato N; Matsuura A; Kikuchi K
    Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody.
    Wang R; Taniguchi M
    J Immunol; 1995 Feb; 154(4):1797-803. PubMed ID: 7836764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell receptor V beta gene expression differs in tumor-infiltrating lymphocytes within primary and metastatic melanoma.
    Nitta T; Bell R; Okumura K; Sato K; Steinman L
    Cancer Res; 1991 Oct; 51(20):5565-9. PubMed ID: 1655255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ; Weil DP; Shamamian P; Rivoltini L; Kawakami Y; Topalian S; Jennings C; Eliyahu S; Rosenberg SA; Nishimura MI
    Cancer Res; 1994 Oct; 54(20):5265-8. PubMed ID: 7522957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis.
    Ferradini L; Roman-Roman S; Azocar J; Avril MF; Viel S; Triebel F; Hercend T
    Cancer Res; 1992 Sep; 52(17):4649-54. PubMed ID: 1324789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T-cell receptor repertoire in tumor infiltrating lymphocytes within malignant brain tumors].
    Nitta T; Ikeda M; Cogen P; Steinman L; Sato K
    No Shinkei Geka; 1992 May; 20(5):559-66. PubMed ID: 1317945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.
    Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT
    Cancer J Sci Am; 1995; 1(2):162-70. PubMed ID: 9166469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
    Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
    Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
    Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
    Ferradini L; Mackensen A; Genevée C; Bosq J; Duvillard P; Avril MF; Hercend T
    J Clin Invest; 1993 Mar; 91(3):1183-90. PubMed ID: 8450047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.
    Puisieux I; Even J; Pannetier C; Jotereau F; Favrot M; Kourilsky P
    J Immunol; 1994 Sep; 153(6):2807-18. PubMed ID: 8077684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
    J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.
    thor Straten P; Becker JC; Seremet T; Bröcker EB; Zeuthen J
    J Clin Invest; 1996 Jul; 98(2):279-84. PubMed ID: 8755635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins.
    Hawes GE; Struyk L; van den Elsen PJ
    J Immunol; 1993 Mar; 150(5):2033-45. PubMed ID: 8436833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck.
    Caignard A; Dietrich PY; Morand V; Lim A; Pannetier C; Leridant AM; Hercend T; Even J; Kourilsky P; Triebel F
    Cancer Res; 1994 Mar; 54(5):1292-7. PubMed ID: 8118818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.